Keratoplasty: Two-year Outcomes of Endothelial Cell Loss and Graft Survival

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044091

Enrollment

Unknown

Registered

2021-03-10

Start date

2014-01-01

Completion date

Unknown

Last updated

2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endothelial dysfunction

Interventions

Case series:FLS-DSEK or FLS-DSEK combined with phacoemulsification

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eighty-four consecutive adult patients (85 eyes) with endothelial dysfunction receiving FLS-DSEK (62 eyes) or FLS-DSEK combined with phacoemulsification cataract surgery and intraocular lens (IOL) implantation (23 eyes) by the same surgeon (W.S.) at Eye Hospital of Shandong First Medical University from May 2013 through April 2016 were included in the analysis. In addition to endothelial dysfunction, the patients also suffered from other eye diseases. This prospective study was approved by the Institutional Review Board of Eye Hospital of Shandong First Medical University (No. 201302) and adhered to the tenets of the Helsinki Declaration. Written informed consent was obtained from each patient.

Exclusion criteria

Exclusion criteria: Lost cases.

Design outcomes

Secondary

Measure	Time frame
postoperative complication;	—

Primary

Measure	Time frame
endothelial cell loss;the central graft thickness;best corrected visual acuity;	—

Countries

China

Contacts

Public ContactWeiyun Shi

Eye Hospital of Shandong First Medical University

weiyunshi@163.com+86 18605310106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026